28 Sep 2018

SEEMA VERMA SPEECH: CMS TO BEGIN AUDITS ON MEDICAID INSURERS

Seema Verma, Centers for Medicare & Medicaid Services Administrator, issued a warning to Medicaid plan sponsors on Thursday, warning the agency would begin unscheduled targeted financial audits. The warning came at the 2018 Medicaid Managed Care Summit during a speech Verma delivered in which she vowed to bring more transparency to

0
27 Sep 2018

SPEECH: CMS ADMINISTRATOR SEEMA VERMA’S REMARKS AT THE 2018 MEDICAID MANAGED CARE SUMMIT SEPT. 27

It is great to be back in front of a room full of professionals dedicated to improving the lives of Medicaid beneficiaries. For me, it’s a little like coming home. I see the faces of the people out working on the front lines, of transforming the American health care system,

0
06 Sep 2018

PENUMBRA ACQUIRES 90% OF MVI HEALTH JV, LAUNCHES THROMBECTOMY DEVICES

  Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology,

0
29 Aug 2018

MEDICAL GROUPS, PATIENT ADVOCATES OPPOSE MEDICARE PLANS TO CONSOLIDATE E/M CODES

More than 150 medical groups sent a letter opposing a government plan to consolidate evaluation and management (E/M) codes, saying it could underpay doctors who treat the sickest patients. In a letter sent to Seema Verma, administrator of the Centers for Medicare & Medicaid Services, the groups — including the American Medical Association

0
21 Aug 2018

ACUSON SEQUOIA ULTRASOUND COMING TO A CITY NEAR YOU

Siemens Medical Solutions USA Inc. is taking its ACUSON Sequoia Ultrasound System on the road with nine stops between Aug. 23 and Oct. 4.   Stops include: August 23: Philadelphia, The Union League August 23: Atlanta, The Westin Buckhead Atlanta August 28: Cincinnati, Hyatt Regency Cincinnati August 30: Detroit, The

0
13 Aug 2018

ENOUGH IS ENOUGH: MEDICAL GROUPS DEMAND HHS STOP STALLING ON INFORMATION BLOCKING

                Enough is enough. The American Academy of Family Physicians (AAFP) joined 13 other medical associations and healthcare organizations Aug. 9 in telling the federal government it has dragged out the regulation-writing process on an important topic far too long. At issue are the information blocking provisions of the 21st Century

0
07 Aug 2018

MICROSOFT IS DEVELOPING A GLASSES-BASED BLOOD PRESSURE MONITOR

            Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and  Edward J.

0
04 Aug 2018

HEALING AT THE MID-LEVEL: TWO MID-LEVEL PRACTITIONERS DISCUSS CHALLENGES, REWARDS, FUTURE OF THEIR PROFESSION

   By Larry Storer Mid-level practitioners in the medical field include occupations of nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists and physician assistants, to name a few. In this article, I asked two mid-level practitioners from American Vein & Vascular Institute to share their thoughts on the occupation,

0
01 Aug 2018

FIRST MR THEATER IN U.S. OPENS AT PARRISH HEALTHCARE IN FLORIDA

  Patients at the Parrish Healthcare Center in Titusville, Fla., are the first to have access to enhanced comfort during Magnetic Resonance (MR) exams thanks to the installation of the nation’s first Vantage Titan / Zen Edition 1.5T MR Theater from Canon Medical Systems USA Inc. The new MR theater projects peaceful, virtual reality

0
01 Aug 2018

GE HEALTHCARE, LANTHEUS BEGIN A PHASE 3 CLINICAL TRIAL OF FLURPIRIDAZ TO TREAT CAD

GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease (CAD), the most common form of heart disease.1 CAD affects an estimated

0